Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Enterprise Value came in at -$45.1 million in Q4 2025, down 1262.38% YoY from $3.9 million in Q4 2024, and down 1521.45% on a QoQ basis from -$2.8 million in Q2 2025.
Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Enterprise Value data on file, last reported at -$45.1 million in Q4 2025.
- Quarterly Enterprise Value fell 1262.38% year-over-year to -$45.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$45.1 million (down 1262.38% YoY) and the FY2025 annual result came in at -$2.8 million, down 154.73% from the prior year.
- Enterprise Value retreated to -$45.1 million in Q4 2025, from -$2.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q2 2024 to a low of -$45.1 million in Q4 2025.
- A 5-year average of -$9.9 million and a median of -$3.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 75.18% — and 2025, when it tumbled 1262.38%.
- Tracing KZIA's Enterprise Value over 5 years: stood at -$11.1 million in 2021, then jumped by 73.93% to -$2.9 million in 2022, then advanced by 21.51% to -$2.3 million in 2023, then slumped by 46.26% to -$3.3 million in 2024, then sank by 1262.38% to -$45.1 million in 2025.
- The last three Enterprise Value figures came in at -$45.1 million (Q4 2025), -$2.8 million (Q2 2025), and -$3.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | -45.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.12 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Dec 31, 2024 | -3.31 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Jun 30, 2023 | -3.50 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Jun 30, 2022 | -5.27 Mn |
| Dec 31, 2021 | -11.07 Mn |
| Jun 30, 2021 | -21.24 Mn |
| Dec 31, 2020 | -14.16 Mn |
| Jun 30, 2020 | -5.74 Mn |
| Dec 31, 2019 | -4.28 Mn |
| Jun 30, 2019 | -3.81 Mn |
| Dec 31, 2018 | -2.75 Mn |
| Jun 30, 2018 | -4.51 Mn |
| Jun 30, 2017 | -10.86 Mn |
| Dec 31, 2016 | -4.98 Mn |
| Jun 30, 2016 | -24.98 Mn |
| Dec 31, 2015 | -2.02 Mn |